Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biological Behavior and Long-Term Outcomes of Carcinoma In Situ in Upper Urinary Tract Managed by Radical Nephroureterectomy.
Inamoto T, Matsuyama H, Ibuki N, Komura K, Takahara K, Fujimoto K, Shiina H, Sakano S, Nagao K, Miyake M, Tatsumi Y, Yasumoto H, Azuma H; Nishinihon Uro-Oncology Collaborative Group. Inamoto T, et al. Among authors: shiina h. J Urol. 2018 Apr;199(4):933-939. doi: 10.1016/j.juro.2017.10.019. Epub 2017 Oct 14. J Urol. 2018. PMID: 29037861
Changes in oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma treated in the last two decades: a retrospective analysis based on a multicenter collaborative study.
Miyake M, Tatsumi Y, Fujimoto K, Nagao K, Sakano S, Matsuyama H, Inamoto T, Azuma H, Yasumoto H, Shiina H; Nishinipon Uro-Oncology Collaborative Group. Miyake M, et al. Among authors: shiina h. Jpn J Clin Oncol. 2016 Dec;46(12):1148-1155. doi: 10.1093/jjco/hyw128. Epub 2016 Aug 30. Jpn J Clin Oncol. 2016. PMID: 27576438
Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Miyake M, Tatsumi Y, Matsumoto H, Nagao K, Matsuyama H, Inamoto T, Azuma H, Yasumoto H, Shiina H, Fujimoto K; Nishinihon Uro-Oncology Collaborative Group. Miyake M, et al. Among authors: shiina h. BJU Int. 2018 May;121(5):764-773. doi: 10.1111/bju.14111. Epub 2018 Jan 21. BJU Int. 2018. PMID: 29281857
Risk stratification by means of biological age-related factors better predicts cancer-specific survival than chronological age in patients with upper tract urothelial carcinoma: a multi-institutional database study.
Inamoto T, Matsuyama H, Ibuki N, Komura K, Fujimoto K, Shiina H, Sakano S, Nagao K, Miyake M, Yasumoto H, Azuma H; Nishinihon Uro-Oncology Collaborative Group. Inamoto T, et al. Among authors: shiina h. Ther Adv Urol. 2018 Nov 11;10(12):403-410. doi: 10.1177/1756287218811050. eCollection 2018 Dec. Ther Adv Urol. 2018. PMID: 30574200 Free PMC article.
Tumor Location Based Segmentation in Upper-Tract Urothelial Carcinoma Impacts on the Urothelial Recurrence-Free Survival: A Multi-Institutional Database Study.
Inamoto T, Matsuyama H, Komura K, Ibuki N, Fujimoto K, Shiina H, Sakano S, Nagao K, Mastumoto H, Miyake M, Tatsumi Y, Yasumoto H, Azuma H. Inamoto T, et al. Among authors: shiina h. Curr Urol. 2020 Dec;14(4):183-190. doi: 10.1159/000499240. Epub 2020 Dec 18. Curr Urol. 2020. PMID: 33488336 Free PMC article.
Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy.
Miyake M, Iida K, Nishimura N, Inoue T, Matsumoto H, Matsuyama H, Fujiwara Y, Komura K, Inamoto T, Azuma H, Yasumoto H, Shiina H, Yonemori M, Enokida H, Nakagawa M, Fukuhara H, Inoue K, Yoshida T, Kinoshita H, Matsuda T, Fujii T, Fujimoto K; Nishinihon Uro-oncology Extensive Collaboration Group. Miyake M, et al. Among authors: shiina h. Eur Urol Open Sci. 2022 May 30;41:95-104. doi: 10.1016/j.euros.2022.05.004. eCollection 2022 Jul. Eur Urol Open Sci. 2022. PMID: 35813249 Free PMC article.
Current chemotherapeutic strategies against bladder cancer.
Mitsui Y, Yasumoto H, Arichi N, Honda S, Shiina H, Igawa M. Mitsui Y, et al. Among authors: shiina h. Int Urol Nephrol. 2012 Apr;44(2):431-41. doi: 10.1007/s11255-011-0009-8. Epub 2011 Jun 12. Int Urol Nephrol. 2012. PMID: 21667254 Review.
Development and external validation of a preoperative nomogram for predicting pathological locally advanced disease of clinically localized upper urinary tract carcinoma.
Yoshida T, Kobayashi T, Kawaura T, Miyake M, Ito K, Okuno H, Murota T, Makita N, Kawakita M, Kawa G, Kitawaki T, Fujimoto K, Matsuyama H, Shiina H, Azuma H, Ogawa O, Kinoshita H, Matsuda T. Yoshida T, et al. Among authors: shiina h. Cancer Med. 2020 Jun;9(11):3733-3741. doi: 10.1002/cam4.2988. Epub 2020 Apr 6. Cancer Med. 2020. PMID: 32253820 Free PMC article.
A case of primary retroperitoneal serous adenocarcinoma.
Arichi N, Yasumoto H, Mitsui Y, Hiraoka T, Honda S, Shiina H, Igawa M. Arichi N, et al. Among authors: shiina h. Int J Urol. 2011 Dec;18(12):844-6. doi: 10.1111/j.1442-2042.2011.02875.x. Epub 2011 Oct 12. Int J Urol. 2011. PMID: 21992013
232 results